Skip to main content
Clinical Trials/NCT01163214
NCT01163214
Completed
Phase 4

Prospective Randomized Study Comparing Regional Anesthetic Blocks and Periarticular Infiltration for the Management of Postoperative Pain After Total Knee Replacement.

Mark J. Spangehl, M.D.1 site in 1 country160 target enrollmentJuly 2010

Overview

Phase
Phase 4
Intervention
Nerve Block
Conditions
Postoperative Pain
Sponsor
Mark J. Spangehl, M.D.
Enrollment
160
Locations
1
Primary Endpoint
Post-Operative Pain
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to compare two methods of postoperative pain management in patients undergoing total knee replacement.

Detailed Description

Patients undergoing total knee replacement will be assigned at random to receive one of two methods of postoperative pain management. Patients assigned to nerve block will receive regional anesthetic nerve block using an indwelling femoral nerve catheter and a single shot sciatic nerve block. Patients assigned to periarticular injection will receive periarticular local injection into the periarticular soft tissues at the time of knee replacement using a combination of ropivacaine, epinephrine, ketorolac, and morphine sulphate. Additionally, all patients will be given a standardized combination of oral analgesic medications preoperatively and postoperatively. All patients will receive a posterior stabilized total knee replacement through an medial parapatellar approach.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
June 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Mark J. Spangehl, M.D.
Responsible Party
Sponsor Investigator
Principal Investigator

Mark J. Spangehl, M.D.

Associate Professor of Orthopedics

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Unilateral primary total knee replacement.
  • Weight 50-125 kg.
  • Age 18-79 years.
  • Intact neurological exam to the surgical lower extremity.
  • Cognitively intact with ability to sign informed consent.

Exclusion Criteria

  • Renal insufficiency with creatinine \>1.5 mg/dL.
  • Allergy to medication used in the study.
  • Using narcotic medication prior to surgery (morphine equivalents \>=20 mg/day for \>7 days.)
  • Prior open knee surgery with regional anesthesia or periarticular injection for post-operative pain management.

Arms & Interventions

Nerve Block

Preoperative femoral block with indwelling femoral catheter and a single shot sciatic block.

Intervention: Nerve Block

Periarticular Injection

Injection combination prior to skin closure.

Intervention: Periarticular Injection

Outcomes

Primary Outcomes

Post-Operative Pain

Time Frame: Afternoon on post-operative Day 1, approximately 14:00

Pain was measured using a linear analog scale for pain, with a scale from 0 (no pain) to 10 points (worst possible pain).

Secondary Outcomes

  • Pain Scores in the Per-protocol Subset (Participants Who Received the Allocated Treatment)(Afternoon on post-operative Day 1, approximately 14:00)
  • Narcotic Use(Intraoperative, Day of surgery, Post-Operative Day 1, Post-Operative Day 2)
  • Straight-leg Raise(Day 1 morning (AM), Day 1 afternoon (PM), Day 2 morning, Day 2 afternoon)
  • Length of Stay in Hospital(Approximately 2 days after surgery)
  • Number of Subjects Who Experienced Neurological Changes Postoperatively(6 weeks postoperative)

Study Sites (1)

Loading locations...

Similar Trials